Perceptive Capital Solutions Corp (Nasdaq: PCSC) is a blank-check company sponsored by Perceptive Advisors, a New York-based investment firm with a long track record in life sciences and healthcare investing. The company filed an 8-K with the SEC on June 10, 2026, signaling a material corporate development in its lifecycle. PCSC targets acquisition opportunities in the biopharmaceutical, medical technology, and healthcare sectors, consistent with Perceptive Advisors' core investment focus. The SPAC remains an active vehicle in the life sciences SPAC universe, where sponsor pedigree and sector expertise are closely watched by institutional investors. For full filing history, timeline data, and deal analytics on PCSC, sign up for SpacDesk at spacdesk.com.